On January 5, 2026, the Trump administration cut the list of universally recommended childhood vaccines from 17 to 11, bypassing the usual expert review process. HHS Secretary Robert F. Kennedy Jr. directed the changes, and Acting CDC Director Jim O'Neill — described by public health experts as having "no clinical or scientific background" — signed off. Vaccines for rotavirus, influenza, hepatitis A, hepatitis B, and meningitis moved to "shared clinical decision-making," meaning doctors and parents now decide individually. A federal court blocked the changes in March 2026, invalidating Kennedy's ACIP appointees. HHS says the ruling left the panel unable to meet. With the FDA's decision on a new mRNA flu vaccine due August 5, that standoff now threatens coverage heading into fall.

1. HHS Can Fix This Anytime — and Won't (The AAP, ACOG, and Dr. Paul Offit)

The ACIP paralysis is a choice, not a court-imposed lockout — and it's already costing lives.

This is a manufactured crisis. The American Academy of Pediatrics said directly that the government "has had and continues to have the power to restore a lawful ACIP and schedule a meeting at any time." A July 2026 Unbiased Science analysis confirmed: fixing ACIP "does not hinge on the outcome of this case" — it's "a choice, not just a scheduling accident."

A new flu vaccine is sitting on the shelf. The FDA's advisory committee voted 9-0 on June 18, 2026, to recommend Moderna's mFlusiva — an mRNA flu shot that showed 27% relative efficacy compared to standard-dose flu shots in trials. But without ACIP's sign-off, most insurers won't cover it, and pharmacists face billing complications that keep it off the table even if patients want it.

Measles is already back. Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia and a former ACIP member, has warned that Kennedy's changes have already increased vaccine hesitancy and coincided with measles resurgence. Before universal hepatitis B vaccination began in 1991, some 18,000 children a year contracted the virus; universal vaccination cut that by 99%. The AAP and ACOG are now issuing independent immunization schedules to fill the federal vacuum, and California, New York, and Illinois have announced they'll follow professional-society guidelines instead of federal ones.

2. But the Old ACIP Was the Problem (Kennedy, Aaron Siri, and Children's Health Defense)

Pharma captured the old ACIP, Kennedy's team says — and his changes are what MAHA voters demanded.

The old system needed disrupting. Kennedy and his team argue the pre-existing ACIP was industry-captured: a committee whose members had financial ties to vaccine manufacturers signing off on a schedule that grew without adequate independent scrutiny. Kennedy's team calls it a restoration of parental rights, not an attack on science.

The Reuters exposé is actually his credential. Children's Health Defense, Kennedy's longtime organization, called the investigation a "hit piece" that revealed how hard he'd worked to reform vaccine policy against entrenched opposition. Aaron Siri, a vaccine litigation attorney, helped vet Kennedy's ACIP appointees — the same ones the court later threw out. He joined the internal HHS policy meetings by speakerphone.

The court created the ACIP problem, not HHS. That's Kennedy's position. His team frames the paralysis as a legal accident — courts blocked his reforms and left the committee without a quorum, and HHS is simply complying. Kennedy's own statement during the expedited appeal filing: "A functioning ACIP is essential to ensuring that vaccine recommendations remain grounded in evidence."

3. His Own People Stopped the Worst of It (FDA Commissioner Makary and NIH's Bhattacharya)

Inside HHS, a quieter coalition blocked Kennedy's most extreme plans — but not before the damage was done.

The real target was the entire schedule. Reuters interviews with 16 current and former officials revealed that Kennedy and his advisor Stefanie Spear had proposed eliminating the entire childhood immunization schedule, replacing all federal vaccine recommendations with individual parent-provider decisions. He also pushed to remove the MMR and polio vaccines. White House officials stopped him.

The moderates held a line. FDA Commissioner Marty Makary and Tracy Beth Høeg, then the acting director of FDA's drug evaluation center, created a "core essential vaccines" list to redirect Kennedy toward the less radical "Make America Denmark" model. NIH Director Jay Bhattacharya blocked Kennedy's $5 billion request to study vaccine-autism links.

They stopped the worst. That's it. These officials are still Trump appointees working within the Kennedy-led HHS. They stopped the most extreme proposals. They did not restore ACIP. The mRNA flu vaccine is still pending — and the August 5 FDA deadline arrives with the committee still dark.

Where This Lands

The AAP says the government can restore a lawful ACIP today and holds HHS responsible for choosing not to. Kennedy's team says the courts caused the paralysis and that the old ACIP deserved disruption. Inside HHS, Makary and Bhattacharya stopped Kennedy's most extreme proposals but haven't moved to fix the committee either. The August 5 FDA decision on Moderna's mRNA flu vaccine is the next test: if FDA approves it without ACIP available to recommend it, millions of adults may find it uncovered heading into the 2026-27 flu season.

Sources